AGLE logo

Aeglea BioTherapeutics, Inc.


AGLE: Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare metabolic diseases. The company competes in the segments of the pharmaceutical, biotechnology and other related markets that address rare genetic diseases.


Show AGLE Financials

Consumer Interest
SEC Filings

Recent trades of AGLE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AGLE's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $30,000 Apr 20, 2023 Issue: None
  • $30,000 Jan 19, 2023 Issue: None
  • $30,000 Oct 18, 2022 Issue: None
  • $20,000 Jul 20, 2022 Issue: Pharmacy
  • $20,000 Apr 20, 2022 Issue: None
  • $30,000 Jan 20, 2022 Issue: None
  • $30,000 Oct 20, 2021 Issue: Health Issues
  • $30,000 Jul 20, 2021 Issue: Health Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues Pharmacy
  • $30,000 Jan 21, 2021 Issue: None
  • $10,000 Oct 20, 2020 Issue: Health Issues Pharmacy
  • $40,000 Aug 03, 2020 Issue: Pharmacy
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AGLE in WallStreetBets Daily Discussion


Recent insights relating to AGLE

CNBC Recommendations

Recent picks made for AGLE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AGLE

Corporate Flights

Flights by private jets registered to AGLE